Claude Michel Wischik

This inventor holds 54 USPTO granted patents and 25 published patent applications, plus 20 CIPO patents and 29 EPO patents, primarily in Phenothiazine Compounds. Top assignees: Wista Laboratories Ltd., Genting Taurx Diagnostic Centre Sdn Bhd, University of Aberdeen. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claude Michel Wischik. Retrieved from https://idiyas.com/inventor/claude-michel-wischik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 54 (Patent Applications = 25)

% Patents Active = 90.7

CIPO Patents = 20 (Patent Applications = 24)

EPO Patents = 29 (Patent Applications = 44)

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 288(Granted Patents)

Forward Citations (Not Self Cited) = 128(Dec 10, 2025)

Location History:

Cambridge, GB (2002 - 2012)
Old Aberdeen Aberdeenshire, GB (2016)
Old Aberdeen, GB (2016 - 2020)
Aberdeen, GB (2008 - 2024)
Aberdeenshire, GB (2010 - 2024)

Company Filing History:

48 out of 59

Wista Laboratories Ltd.

patents

2 out of 2

Genting Taurx Diagnostic Centre Sdn Bhd

patents

2 out of 51

University of Aberdeen

patents

4. 2 out of 834,513

Other

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Phenothiazine Salts

Neurological Testing

Diaminophenothiazines

Tau Inhibition

Mild Cognitive Impairment

High Purity Compounds

Synthesis Methods

Therapeutic Use

Aggregated Tau Ligands

Tauopathies

Protein Aggregation

Medical Methods

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624096 - ANTI-TAU ANTIBODIES AND METHODS OF USE THEREOF (2026-05-12),

2. 12505911 - Adaptive neurological testing method (2025-12-23),

3. 12324810 - 3, 7-diamino-10H-phenothiazine salts and their use (2025-06-10),

4. 12310973 - Administration and dosage of diaminophenothiazines (2025-05-27),

5. 12280061 - Optimised dosage of diaminophenothiazines in populations (2025-04-21),

6. 12263175 - Optimised dosage of diaminophenothiazines in populations (2025-04-01),

7. 12128051 - Administration and dosage of diaminophenothiazines (2024-10-29),

8. 12064439 - Phenothiazine diaminium salts and their use (2024-08-20),

9. 11951110 - 3, 7-diamino-10H-phenothiazine salts and their use (2024-04-09),

10. 11878021 - Methods of synthesis and/or purification of diaminophenothiazinium compounds (2024-01-23),

11. 11759469 - Administration and dosage of diaminophenothiazines (2023-09-19),

12. 11344558 - 3, 7-diamino-10H-phenothiazine salts and their use (2022-05-31),

13. 11180464 - Phenothiazine diaminium salts and their use (2021-11-23),

14. 11116772 - Medical methods utilising high purity diaminophenothiazinium compounds (2021-09-14),

15. 11065256 - Administration and dosage of diaminophenothiazines (2021-07-20),

Title: Claude Michel Wischik - Pioneering Inventor from Aberdeen, GB

Introduction: Claude Michel Wischik is a renowned inventor hailing from Aberdeen, United Kingdom, known for his groundbreaking contributions to the field of innovation and patenting.

Latest Patents: Wischik holds several patents in the medical and pharmaceutical sectors, with his most recent inventions focusing on novel treatments for neurodegenerative diseases.

Career Highlights: With a distinguished career spanning over three decades, Wischik has been instrumental in developing cutting-edge technologies that have revolutionized the healthcare industry. His work has significantly impacted the lives of countless individuals worldwide.

Collaborations: Throughout his career, Wischik has collaborated with leading researchers, scientists, and medical professionals to bring his inventions to fruition. His collaborative efforts have led to the successful implementation of innovative solutions in the medical field.

Conclusion: Claude Michel Wischik's relentless pursuit of innovation and his dedication to improving healthcare have solidified his position as a trailblazing inventor in Aberdeen, GB, and beyond. His pioneering spirit continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.